Cholinergic forebrain degeneration in the APPswe/PS1ΔE9 transgenic mouse
- 31 October 2007
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 28 (1), 3-15
- https://doi.org/10.1016/j.nbd.2007.06.015
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1ΔE9 Transgenic MiceJournal of Neuroscience, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Cholinergic neuropathology in a mouse model of Alzheimer's diseaseJournal of Comparative Neurology, 2003
- Neuropathology of Mice Carrying Mutant APPswe and/or PS1M146L Transgenes: Alterations in the p75NTR Cholinergic Basal Forebrain Septohippocampal PathwayExperimental Neurology, 2001
- A vector for expressing foreign genes in the brains and hearts of transgenic miceGenetic Analysis: Biomolecular Engineering, 1996
- Nerve growth factor in Alzheimerʼs disease: defective retrograde transport to nucleus basalisNeuroReport, 1995
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrainExperimental Neurology, 1989
- Hypothesis: Interference with Axonal Transport of Neurofilament as a Common Pathogenetic Mechanism in Certain Diseases of the Central Nervous SystemNew England Journal of Medicine, 1985
- Acetylcholine and choline levels in post-mortem human brain tissue: Preliminary observations in Alzheimer's diseaseLife Sciences, 1980